Cheng, K., Seita, Y., Whelan, E. C., Yokomizo, R., Hwang, Y. S., Rotolo, A., Krantz, I. D., Ginsberg, J. P., Kolon, T. F., Lal, P., Luo, X., Pierorazio, P. M., Linn, R. L., Ryeom, S., & Sasaki, K. (2024). Defining the cellular origin of seminoma by transcriptional and epigenetic mapping to the normal human germline. Cell Reports, 43(6), 114323. https://doi.org/10.1016/j.celrep.2024.114323

Schultz, K. A. P., Chintagumpala, M., Piao, J., Chen, K. S., Shah, R., Gartrell, R. D., Christison-Lagay, E., Pashnakar, F., Berry, J. L., O’Neill, A. F., Vasta, L. M., Flynn, A., Mitchell, S. G., Seynnaeve, B. KN., Rosenblum, J., Potter, S. L., Kamihara, J., Rodriguez-Galindo, C., Hawkins, D. S., & Laetsch, T. W. (2023). Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective. EJC Paediatric Oncology, 2, 100024. https://doi.org/10.1016/j.ejcped.2023.100024

Mohyuddin, G. R., Chakraborty, R., Cliff, E. R. S., & Derman, B. A. (2023). Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey. EClinicalMedicine, 65, 102272. https://doi.org/10.1016/j.eclinm.2023.102272

Chakraborty, R., Al Hadidi, S., Scheffer Cliff, E. R., & Mohyuddin, G. R. (2023). Is aggressive treatment of smoldering myeloma the path to curing myeloma? Blood Advances, 7(15), 3932–3935. https://doi.org/10.1182/bloodadvances.2023009658